ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

A Proof of Concept for Liver Graft Modification Using Warm Ex Vivo Perfusion – “It Is Not Just About Rescuing Marginal Grafts”.

N. Goldaracena, J. Echeverri, N. Selzner, D. Grant, J. Feld, M. Selzner.

Toronto General Hospital, University of Toronto, Toronto, Canada

Meeting: 2017 American Transplant Congress

Abstract number: 212

Keywords: Liver preservation

Session Information

Session Name: Concurrent Session: Emerging Interventions in Ischemia Reperfusion Injury

Session Type: Concurrent Session

Date: Monday, May 1, 2017

Session Time: 2:30pm-4:00pm

 Presentation Time: 2:30pm-2:42pm

Location: E351

Background: The active metabolism during normothermic ex vivo liver perfusion (NEVLP) offers a new opportunity to use the preservation time for graft modification and repair strategies. One possible strategy, as “proof of concept”, is the induction of resistance against infection Hepatitis C virus (HCV). HCV replication is dependent on the presence of miRNA-122. Miravirsen, a locked-nucleic acid oligonucleotide, sequesters miR-122 and inhibits HCV replication.

Methods: Pig livers were treated with miravirsen during NEVLP or cold storage (CS) and miravirsen absorption, miR-122 sequestration and miR-122 target gene derepression were assessed before and after LT.

Results: In vitro data confirmed miravirsen suppression of HCV replication after established infection and prevented HCV infection with pre-treatment of cells, analogous to the pre-treatment of grafts in the transplant setting. NEVLP improved miravirsen uptake compared to CS Significant miR-122 sequestration (p<0.05) and miR-122 target gene derepression (p<0.01) were seen with NEVLP but not with CS prior to pig LT. Conclusion: NEVLP provides a novel platform for graft modification, such as inducing resistance against HCV infection, using nucleic acid oligonucleotide.

CITATION INFORMATION: Goldaracena N, Echeverri J, Selzner N, Grant D, Feld J, Selzner M. A Proof of Concept for Liver Graft Modification Using Warm Ex Vivo Perfusion – “It Is Not Just About Rescuing Marginal Grafts”. Am J Transplant. 2017;17 (suppl 3).

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Goldaracena N, Echeverri J, Selzner N, Grant D, Feld J, Selzner M. A Proof of Concept for Liver Graft Modification Using Warm Ex Vivo Perfusion – “It Is Not Just About Rescuing Marginal Grafts”. [abstract]. Am J Transplant. 2017; 17 (suppl 3). https://atcmeetingabstracts.com/abstract/a-proof-of-concept-for-liver-graft-modification-using-warm-ex-vivo-perfusion-it-is-not-just-about-rescuing-marginal-grafts/. Accessed May 25, 2025.

« Back to 2017 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences